EMERALD ADVISERS, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 30 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$2,304,000
+90.6%
176,5140.0%0.10%
+77.6%
Q2 2016$1,209,000
-23.5%
176,514
+5.6%
0.06%
-24.7%
Q1 2016$1,580,000
-33.8%
167,185
-29.5%
0.08%
-31.9%
Q4 2015$2,387,000
+57.0%
237,070
+123.2%
0.11%
+43.0%
Q3 2015$1,520,000106,2010.08%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders